BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 856 filers reported holding BAXTER INTL INC in Q2 2024. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $697,440 | -21.3% | 20,850 | +0.6% | 0.21% | -22.6% |
Q1 2024 | $885,789 | +10.3% | 20,725 | -0.2% | 0.27% | +1.9% |
Q4 2023 | $803,162 | +26.7% | 20,775 | +23.7% | 0.27% | +14.5% |
Q3 2023 | $634,035 | -19.4% | 16,800 | -2.7% | 0.24% | -15.5% |
Q2 2023 | $787,048 | +10.8% | 17,275 | -1.4% | 0.28% | +5.3% |
Q1 2023 | $710,408 | -17.8% | 17,515 | +3.2% | 0.26% | -19.8% |
Q4 2022 | $864,714 | -0.6% | 16,965 | +5.0% | 0.33% | -9.6% |
Q3 2022 | $870,000 | -16.2% | 16,155 | 0.0% | 0.36% | -10.1% |
Q2 2022 | $1,038,000 | -15.7% | 16,155 | +1.7% | 0.40% | -3.8% |
Q1 2022 | $1,231,000 | -9.7% | 15,880 | 0.0% | 0.42% | -6.7% |
Q4 2021 | $1,363,000 | +7.4% | 15,880 | +0.6% | 0.45% | -2.0% |
Q3 2021 | $1,269,000 | -0.1% | 15,785 | 0.0% | 0.46% | +0.2% |
Q2 2021 | $1,270,000 | -9.0% | 15,785 | -4.5% | 0.46% | -12.6% |
Q1 2021 | $1,395,000 | +7.7% | 16,535 | +2.4% | 0.52% | +2.3% |
Q4 2020 | $1,295,000 | -0.5% | 16,145 | -0.3% | 0.51% | -10.5% |
Q3 2020 | $1,302,000 | -6.9% | 16,195 | -0.3% | 0.57% | -11.7% |
Q2 2020 | $1,398,000 | +5.7% | 16,245 | -0.3% | 0.65% | -10.0% |
Q1 2020 | $1,323,000 | -2.5% | 16,295 | +0.5% | 0.72% | +26.9% |
Q4 2019 | $1,357,000 | -4.4% | 16,220 | 0.0% | 0.57% | -10.8% |
Q3 2019 | $1,419,000 | +6.9% | 16,220 | 0.0% | 0.64% | +4.9% |
Q2 2019 | $1,328,000 | +0.5% | 16,220 | -0.2% | 0.61% | -3.0% |
Q1 2019 | $1,321,000 | +22.7% | 16,245 | -0.8% | 0.63% | +10.8% |
Q4 2018 | $1,077,000 | -14.7% | 16,370 | 0.0% | 0.56% | -2.8% |
Q3 2018 | $1,262,000 | +3.8% | 16,370 | -0.6% | 0.58% | -1.5% |
Q2 2018 | $1,216,000 | +13.4% | 16,470 | 0.0% | 0.59% | +8.5% |
Q1 2018 | $1,072,000 | 0.0% | 16,470 | -0.8% | 0.54% | +3.6% |
Q4 2017 | $1,072,000 | +1.8% | 16,595 | -1.1% | 0.52% | -2.6% |
Q3 2017 | $1,053,000 | +3.4% | 16,775 | -0.3% | 0.54% | -1.1% |
Q2 2017 | $1,018,000 | +16.7% | 16,829 | 0.0% | 0.54% | +15.2% |
Q1 2017 | $872,000 | +16.4% | 16,829 | -0.4% | 0.47% | +11.6% |
Q4 2016 | $749,000 | -9.3% | 16,904 | -2.6% | 0.42% | -12.4% |
Q3 2016 | $826,000 | +13.2% | 17,354 | +7.5% | 0.48% | +11.0% |
Q2 2016 | $730,000 | +9.9% | 16,140 | -0.2% | 0.44% | +4.6% |
Q1 2016 | $664,000 | +35.8% | 16,165 | +26.1% | 0.42% | +30.3% |
Q4 2015 | $489,000 | – | 12,815 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |